Articles Referencing GIVN

Zacks.com

Biolase Gets FDA Nod for EPIC 10S - Analyst Blog

Recently, a pioneer in manufacturing and distributing dental lasers, BIOLASE, Inc. ( BIOL ) obtained regulatory clearance from the U.S. Food & Drug Administration (FDA) for its EPIC... Read >>

Zacks.com

Cyberonics Stands Out at Outperform - Analyst Blog

On Apr 10, we reaffirmed our long-term Outperform recommendation on Cyberonics Inc. ( CYBX ) based on consistent strong results and excellent growth potential. This prominent player in the... Read >>

Zacks.com

Thoratec Upgraded to Neutral - Analyst Blog

On Apr 11, we upgraded Thoratec Corp. ( THOR ), a leader in mechanical circulatory assistance devices to Neutral, based on its prospects. The company is expected to report first quarter... Read >>

Zacks.com

FDA Approves TFX's ISO-Gard Mask - Analyst Blog

Recently, Teleflex Incorporated ( TFX ) obtained regulatory clearance from the U.S. Food & Drug Administration (FDA) for its ISO-Gard Mask with ClearAir Technology. This new product... Read >>

Zacks.com

LIFE Takeover Battle Heats Up - Analyst Blog

In its ongoing quest for strategic acquisitions, Thermo Fisher Scientific Inc. ( TMO ) is not ready to easily lose its chance to takeover Life Technologies ( LIFE ). According... Read >>

Zacks.com

Will Thermo Fisher Buy LIFE? - Analyst Blog

Following a rumor that Life Technologies ( LIFE ) would be acquired by its peer Thermo Fisher Scientific Inc. ( TMO ) or by a consortium of a number of private equity firms for... Read >>

Zacks.com

New Bioinformatics Tools by LIFE - Analyst Blog

Life Technologies Corporation ( LIFE ) recently revealed a couple of new bioinformatics solutions. These offerings will work on the Oncomine platform, which was added to the company's... Read >>

Zacks.com

HMA Previews 1Q Earnings Results - Analyst Blog

Health Management Associates ( HMA ), a leading operator of general acute care hospitals, recently previewed earnings results for the first quarter of 2013. Health Management expects net... Read >>

Zacks.com

Hologic Reiterated at Neutral - Analyst Blog

On Apr 5, we reaffirmed our long-term Neutral recommendation on Hologic ( HOLX ) as the numerous headwinds in play might limit the growth prospects of the company. This leading player in... Read >>

Zacks.com

MDT to Grow Endovascular Biz Globally - Analyst Blog

Medtronic Inc. ( MDT ) has further strengthened its endovascular portfolio. The company, with the receipt of CE Mark approval for the Sentrant Introducer Sheath, will be launching this... Read >>

Zacks.com

Another Adoption of Masimo - Analyst Blog

Masimo Corporation ( MASI ), a leader in non-invasive monitoring technology, recently revealed that the East Tennessee Children???s Hospital has installed Masimo Patient SafetyNet. This... Read >>

Zacks.com

CYBX Resumes Reimbursement Efforts - Analyst Blog

Cyberonics ( CYBX ) recently provided further information on its reimbursement claim submission to the Centers for Medicare & Medicaid Services (CMS). The leading player in the... Read >>

Zacks.com

Milestone for Accuray TomoTherapy - Analyst Blog

Radiosurgery systems maker, Accuray Incorporated ( ARAY ) announced that Germany-based Heidelberg University Hospital is the first to use its latest Tomotherapy technology for patient... Read >>

Zacks.com

Medtronic Remains at Neutral - Analyst Blog

We recently reinstated our Neutral recommendation on Medtronic, Inc. ( MDT ), a leading medical devices company. While we are to-some-extent relieved with the signs of stability in... Read >>

Zacks.com

Still Neutral on Merge Healthcare - Analyst Blog

On Apr 2, 2013, we reaffirmed our long-term Neutral recommendation on Merge Healthcare Incorporated ( MRGE ) as the company's bright growth prospects are to some extent dwarfed... Read >>

Displaying 1-15 of 76
<< first < previous 1 2 3 4 5 6 next > last >>